1. Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules.
- Author
-
He, Zhang-Xu, Gong, Yun-Peng, Zhang, Xin, Ma, Li-Ying, and Zhao, Wen
- Subjects
- *
PYRIDAZINES , *DRUG marketing , *ARCHAEOLOGICAL human remains , *STRUCTURE-activity relationships , *ANTINEOPLASTIC agents - Abstract
Identification of potent anticancer agents with high selectivity and low toxicity remains on the way to human health. Pyridazine featuring advantageous physicochemical properties and antitumor potential usually is regarded as a central core in numerous anticancer derivatives. There are several approved pyridazine-based drugs in the market and analogues currently going through different clinical phases or registration statuses, suggesting pyridazine as a promising drug-like scaffold. The current review is intended to provide a comprehensive and updated overview of pyridazine derivatives as potential anticancer agents. In particular, we focused on their structure-activity relationship (SAR) studies, design strategies, binding modes and biological activities in the hope of offering novel insights for further rational design of more active and less toxic anticancer drugs. Image 1 • Pyridazine is a privileged scaffold with two nitrogen atoms in a 1, 2-relationship. • The advances of pyridazine-based anticancer derivatives were reviewed. • Pyridazine derivatives were classified into five categories based on their structures. • This review focused on SARs analysis, design strategies, biological activities. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF